Skip to content

Hemodynamic effects of vasopressor on uterine and placenta

Hemodynamic effects of vasopressor on uterine and placenta

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003224
Enrollment
Unknown
Registered
2013-05-13
Start date
2013-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supine hypotensive syndrome

Interventions

Ephedrine:infusion of Ephedrine
phenylephrine50:infusion of phenylephrine50ug/min.
phenylephrine25:infusion of phenylephrine25ug/min.
control:no infusion

Sponsors

The affiliated Jiangyin hospital of Southeast University Medical school
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Eighty in-term parturients with singleton scheduled for selective Cesarean section under spinal anesthesia, ASA I-II, aged 20 to 38 years old, pregnant 37 to 41 weeks.

Exclusion criteria

Exclusion criteria: Parturients with a history of hypertension, diabetes, pre-eclampsia, heart disease, placenta praevia,, or a haemoglobin concentration of less than 7 g/dl, height 170 cm, weight90Kg,were excluded from the study.

Design outcomes

Primary

MeasureTime frame
blood flow volume;PI;

Countries

China

Contacts

Public ContactQian Yanning
yanning_qian@aliyun.com+86 13951701214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026